Follow up immunogenicity of a mixed vaccination schedule with one dose of nonavalent and one dose of bivalent HPV vaccines 36&#160;months post-vaccination among boys and girls.

Gardasil 9 (human papillomavirus 9-valent vaccine, recombinant) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42691819

Chantal Sauvageau; Elizabeth R Unger; Gitika Panicker; Iulia Gabriela Ionescu; Manale Ouakki; Olivier Breton; Vladimir Gilca

Sep 4, 2026